Clinical trial
Combination of Corticotherapy and Intensive Insulin Therapy for Septic Shock
NCT00320099 · University of Versailles, Other · Completed
Key facts
| NCT number | NCT00320099 |
|---|---|
| Title | Combination of Corticotherapy and Intensive Insulin Therapy for Septic Shock |
| Official title | Phase 3 Study of Corticotherapy (Hydrocortisone Alone Versus Hydrocortisone Plus Fludrocortisone) Versus Corticotherapy Plus Intensive Insulin Therapy for Septic Shock |
| Acronym | COIITSS |
| Lead sponsor | University of Versailles, Other |
| Collaborators | Assistance Publique - Hôpitaux de Paris |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Septic Shock |
| Intervention type | Drug |
| Interventions | recombinant human insulin, hydrocortisone, fludrocortisone, Hydrocortisone |
| Enrollment | 508 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | May 3, 2006 |
| Last update posted | Apr 6, 2010 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: